TM vs TOVX · P/E 9.7, rev $234.60B vs rev $300.0K
Toyota Motor Corporation ADR (TM) versus Theriva Biologics Inc. (TOVX) — a side-by-side from cached financials, not a winner call.
Toyota Motor Corporation ADR (TM) is a auto manufacturers company listed on NYSE.
Theriva Biologics Inc. (TOVX) is a biotechnology company listed on NYSE MKT.
Latest reported TM revenue for 2013-03-31 was $234.60B. Net income was $10.23B. Revenue was up 3.8% from 2012-03-31 to 2013-03-31. TM currently screens at market cap $211.00B and trailing P/E 9.7.
Latest reported TOVX revenue for 2026-06-30 was $300.0K. Net income was -$5.3M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. TOVX currently screens at market cap $12.4M.
TM currently screens at market cap $211.00B and trailing P/E 9.7. TOVX currently screens at market cap $12.4M.
Not investment advice. Open the TM and TOVX stock pages for the full models.
Not investment advice.